Novel Oral Antifungal Treatment for Vulvovaginal Candidiasis
With Jack D. Sobel, MD Dr. Jack Sobel talks about ibrexafungerp, a first-in-class oral triterpenoid antifungal agent approved for the treatment of acute vulvovaginal candidiasis. “Ibrexafungerp (Brexafemme, Scynexis) is a first-in-class oral triterpenoid antifungal agent approved for the treatment of acute vulvovaginal candidiasis (VVC). Post-approval clinical experience is needed to fully understand the optimal use […]
This Month: The San Diego Dermatology Symposium
Dr. Jashin Wu details the upcoming San Diego Dermatology Symposium designed to educate and inspire dermatologists, residents, and other medical professionals. “I’m hoping you can join us for the third annual San Diego dermatologist Symposium on March 11 through 13 of this year,” said Jashin J. Wu, MD, FAAD, Founder and Course Director of the San […]